Identification of the Epigenetic Reader BRD4 As a Novel Therapeutic Target in JAK2 V617F+MPN Cells

被引：0
|
作者：
Keller, Alexandra [1 ,2 ]
Peter, Barbara [1 ,2 ]
Zuber, Johannes [3 ]
Staber, Philipp Bernhard [2 ]
Bettelheim, Peter [4 ]
Valent, Peter [1 ,2 ]
Hadzijusufovic, Emir [1 ,2 ,5 ]
机构：
[1] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria
[2] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria
[3] Res Inst Mol Pathol IMP, Vienna, Austria
[4] Elisabethinen Hosp, Dept Med 1, Linz, Austria
[5] Univ Vet Med Vienna, Internal Med, Small Anim Clin, Dept Compan Anim & Horses, Vienna, Austria
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] TARGETING OF BRD4 AS A NOVEL THERAPEUTIC CONCEPT IN JAK2 V617F+MPN
    Keller, A.
    Peter, B.
    Zuber, J.
    Berger, D.
    Staber, P. B.
    Bettelheim, P.
    Valent, P.
    Hadzijusufovic, E.
    HAEMATOLOGICA, 2016, 101 : 89 - 89
  • [2] Evaluation of BRD4 as potential target in JAK2 V617F+MPN cells
    Keller, A.
    Peter, B.
    Zuber, J.
    Valent, P.
    Hadzijusufovic, E.
    Oncology Research and Treatment, 2015, 38 : 226 - 227
  • [3] Identification of the Epigenetic Reader BRD4 As a Novel Potential Target in Ph plus CML
    Peter, Barbara
    Eisenwort, Gregor
    Stefanzl, Gabriele
    Berger, Daniela
    Sperr, Wolfgang R.
    Zuber, Johannes
    Valent, Peter
    BLOOD, 2015, 126 (23)
  • [4] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [5] Validation of the Epigenetic Reader and Histone Acetyltransferase BRD4 as a Therapeutic Target in a Murine Colitis Model
    Tian, Bing
    Villeger, Romain
    Liu, Ziqing
    Chen, Haiying
    Zhou, Jia
    Pinchuk, Irina
    Brasier, Allan
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S86 - S86
  • [6] Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients
    Pearson, Stella
    Blance, Rognvald
    Yan, Fei
    Hsieh, Ya-Ching
    Geary, Bethany
    Amaral, Fabio M. R.
    Somervaille, Tim C. P.
    Kirschner, Kristina
    Whetton, Anthony D. D.
    Pierce, Andrew
    PLOS ONE, 2023, 18 (05):
  • [7] Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling
    Brasier, Allan R.
    Zhou, Jia
    DRUG DISCOVERY TODAY, 2020, 25 (01) : 126 - 132
  • [8] JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the "hypermutability" hypothesis?
    Stolyar, M. A.
    Klimova, O. A.
    Gorbenko, A. S.
    Brenner, E. V.
    Titov, S. E.
    Ivanov, M. K.
    Olkhovskiy, I. A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : E8 - E10
  • [9] Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients
    Lange, Thoralf
    Edelmann, Anja
    Siebolts, Uwe
    Nehring, Claudia
    Jaeckel, Nadja
    Cross, Michael
    Jacqueline, Maier
    Niederwieser, Dietger
    Wickenhauser, Claudia
    BLOOD, 2010, 116 (21) : 1421 - 1421
  • [10] 不同MPN JAK2～(V617F)突变的临床检测方法比较
    丁忠奇
    李毅
    郑国华
    中国医学工程, 2013, 21 (05) : 96 - 97
12345